Oxandrolone Treatment Results in an Increased Risk of Gonadarche in Prepubertal Boys With Klinefelter Syndrome

Overview

Journal J Clin Endocrinol Metab

Publisher Oxford University Press

Specialty Endocrinology

Date 2018 Jun 23

PMID 29931143

Citations 9

Authors

Shanlee M Davis

Najiba Lahlou

Matthew Cox-Martin

Karen Kowal

Philip S Zeitler

Judith L Ross

Affiliations

Soon will be listed here.

Abstract

Context: Klinefelter syndrome (KS) is a common genetic condition in which males have an extra X chromosome. KS is associated with testosterone deficiency, neurodevelopmental delays, and cardiometabolic disorders. There has been recent interest in prepubertal androgen treatment; however, the effects on puberty and gonadal function are unknown.

Objective: To compare onset of puberty and testicular function in prepubertal boys treated with 2 years of oxandrolone (Ox) vs placebo (Pl).

Design: Double-blind, randomized, controlled trial.

Setting: Single tertiary care referral center.

Participants: Eighty prepubertal boys with KS; mean age: 8.0 ± 2.2 years (range: 4 to 12).

Interventions: Ox 0.05 mg/kg vs identical-appearing Pl capsule given for 2 years.

Outcome Measures: Onset of gonadarche (testicular volume ≥4 mL) and onset of pubarche (Tanner 2 pubic hair); change in testicular hormone concentrations.

Results: Ox-treated group had 20.5 times higher odds of reaching gonadarche (OR 95% CI: 6.5, 77.8) and 28.1 times higher odds of reaching pubarche (OR 95% CI: 8.8, 110.4) during the 2-year study period after adjusting for baseline age. Gonadarche and pubarche both occurred at a younger age in the Ox group (gonadarche: 9.8 ± 1.5 vs 12.1 ± 1.0 years, P < 0.001; pubarche: 10.2 ± 1.1 vs 11.6 ± 1.3 years, P = 0.02). Serum concentrations of testicular hormones and gonadotropins were not different between groups.

Conclusions: Two years of Ox treatment in prepubertal boys with KS results in an increased risk of early gonadarche, on average 2 years earlier than in Pl-treated boys. Ox did not affect serum concentrations of testicular hormones.

Citing Articles

Approaches to Identify Factors Associated with Pubertal Timing in Self-Limited Delayed Puberty.

Zhu J, Liu E, Feld A, Jonsdottir-Lewis E, Shirey A, Feldman H Horm Res Paediatr. 2022; 96(3):267-277.

PMID: 36007499 PMC: 9958281. DOI: 10.1159/000526590.

Recent advancement in the treatment of boys and adolescents with hypogonadism.

Rey R Ther Adv Endocrinol Metab. 2022; 13:20420188211065660.

PMID: 35035874 PMC: 8753232. DOI: 10.1177/20420188211065660.

Attenuated androgen discontinuation in patients with hereditary angioedema: a commented case series.

Maurer M, Magerl M, Aygoren-Pursun E, Bork K, Farkas H, Longhurst H Allergy Asthma Clin Immunol. 2022; 18(1):4.

PMID: 35027083 PMC: 8759255. DOI: 10.1186/s13223-021-00644-0.

Cortical Bone Mass is Low in Boys with Klinefelter Syndrome and Improves with Oxandrolone.

Vogiatzi M, Davis S, Ross J J Endocr Soc. 2021; 5(4):bvab016.

PMID: 33733020 PMC: 7947965. DOI: 10.1210/jendso/bvab016.

Fast and Sensitive Screening of Oxandrolone and Its Major Metabolite 17-Epi-Oxandrolone in Human Urine by UHPLC-MS/MS with On-Line SPE Sample Pretreatment.

Galba J, Piestansky J, Kovac A, Olesova D, Cehlar O, Kertys M Molecules. 2021; 26(2).

PMID: 33477515 PMC: 7831107. DOI: 10.3390/molecules26020480.

References

Wosnitzer M, Paduch D . Endocrinological issues and hormonal manipulation in children and men with Klinefelter syndrome. Am J Med Genet C Semin Med Genet. 2013; 163C(1):16-26. DOI: 10.1002/ajmg.c.31350. View

Davis S, Howell S, Wilson R, Tanda T, Ross J, Zeitler P . Advances in the Interdisciplinary Care of Children with Klinefelter Syndrome. Adv Pediatr. 2016; 63(1):15-46. PMC: 5340500. DOI: 10.1016/j.yapd.2016.04.020. View

Samango-Sprouse C, Sadeghin T, Mitchell F, Dixon T, Stapleton E, Kingery M . Positive effects of short course androgen therapy on the neurodevelopmental outcome in boys with 47,XXY syndrome at 36 and 72 months of age. Am J Med Genet A. 2013; 161A(3):501-8. DOI: 10.1002/ajmg.a.35769. View

Orr R, Fiatarone Singh M . The anabolic androgenic steroid oxandrolone in the treatment of wasting and catabolic disorders: review of efficacy and safety. Drugs. 2004; 64(7):725-50. DOI: 10.2165/00003495-200464070-00004. View

Ross J, Kushner H, Kowal K, Bardsley M, Davis S, Reiss A . Androgen Treatment Effects on Motor Function, Cognition, and Behavior in Boys with Klinefelter Syndrome. J Pediatr. 2017; 185:193-199.e4. PMC: 6754744. DOI: 10.1016/j.jpeds.2017.02.036. View

Salehpour S, Alipour P, Razzaghy-Azar M, Ardeshirpour L, Shamshiri A, Monfared M . A double-blind, placebo-controlled comparison of letrozole to oxandrolone effects upon growth and puberty of children with constitutional delay of puberty and idiopathic short stature. Horm Res Paediatr. 2010; 74(6):428-35. DOI: 10.1159/000315482. View

Bojesen A, Juul S, Gravholt C . Prenatal and postnatal prevalence of Klinefelter syndrome: a national registry study. J Clin Endocrinol Metab. 2003; 88(2):622-6. DOI: 10.1210/jc.2002-021491. View

Galvao T, Silva M, Zimmermann I, Souza K, Martins S, Pereira M . Pubertal timing in girls and depression: a systematic review. J Affect Disord. 2013; 155:13-9. DOI: 10.1016/j.jad.2013.10.034. View

Pescovitz O, Comite F, Cassorla F, Dwyer A, Poth M, Sperling M . True precocious puberty complicating congenital adrenal hyperplasia: treatment with a luteinizing hormone-releasing hormone analog. J Clin Endocrinol Metab. 1984; 58(5):857-61. DOI: 10.1210/jcem-58-5-857. View

10.

Kang E, Cho J, Choi J, Yoo H . Etiology and therapeutic outcomes of children with gonadotropin-independent precocious puberty. Ann Pediatr Endocrinol Metab. 2016; 21(3):136-142. PMC: 5073159. DOI: 10.6065/apem.2016.21.3.136. View

11.

Nieschlag E, Ferlin A, Gravholt C, Gromoll J, Kohler B, Lejeune H . The Klinefelter syndrome: current management and research challenges. Andrology. 2016; 4(3):545-9. DOI: 10.1111/andr.12208. View

12.

Davis S, Lahlou N, Bardsley M, Temple M, Kowal K, Pyle L . Gonadal function is associated with cardiometabolic health in pre-pubertal boys with Klinefelter syndrome. Andrology. 2016; 4(6):1169-1177. PMC: 5233646. DOI: 10.1111/andr.12275. View

13.

Sheanon N, Backeljauw P . Effect of oxandrolone therapy on adult height in Turner syndrome patients treated with growth hormone: a meta-analysis. Int J Pediatr Endocrinol. 2015; 2015(1):18. PMC: 4551522. DOI: 10.1186/s13633-015-0013-3. View

14.

Fennoy I . Testosterone and the child (0-12 years) with Klinefelter syndrome (47XXY): a review. Acta Paediatr. 2011; 100(6):846-50. DOI: 10.1111/j.1651-2227.2011.02184.x. View

15.

Davis S, Cox-Martin M, Bardsley M, Kowal K, Zeitler P, Ross J . Effects of Oxandrolone on Cardiometabolic Health in Boys With Klinefelter Syndrome: A Randomized Controlled Trial. J Clin Endocrinol Metab. 2016; 102(1):176-184. PMC: 5413098. DOI: 10.1210/jc.2016-2904. View

16.

Porro L, Herndon D, Rodriguez N, Jennings K, Klein G, Mlcak R . Five-year outcomes after oxandrolone administration in severely burned children: a randomized clinical trial of safety and efficacy. J Am Coll Surg. 2012; 214(4):489-502. PMC: 3412530. DOI: 10.1016/j.jamcollsurg.2011.12.038. View

17.

Crowne E, Wallace W, Moore C, Mitchell R, Robertson W, Holly J . Effect of low dose oxandrolone and testosterone treatment on the pituitary-testicular and GH axes in boys with constitutional delay of growth and puberty. Clin Endocrinol (Oxf). 1997; 46(2):209-16. DOI: 10.1046/j.1365-2265.1997.t01-1-1150928.x. View

18.

Samango-Sprouse C, Stapleton E, Lawson P, Mitchell F, Sadeghin T, Powell S . Positive effects of early androgen therapy on the behavioral phenotype of boys with 47,XXY. Am J Med Genet C Semin Med Genet. 2015; 169(2):150-7. DOI: 10.1002/ajmg.c.31437. View

19.

Papadimitriou A, Wacharasindhu S, Pearl K, Preece M, Stanhope R . Treatment of constitutional growth delay in prepubertal boys with a prolonged course of low dose oxandrolone. Arch Dis Child. 1991; 66(7):841-3. PMC: 1793227. DOI: 10.1136/adc.66.7.841. View

20.

Aksglaede L, Wikstrom A, Rajpert-De Meyts E, Dunkel L, Skakkebaek N, Juul A . Natural history of seminiferous tubule degeneration in Klinefelter syndrome. Hum Reprod Update. 2005; 12(1):39-48. DOI: 10.1093/humupd/dmi039. View